The immunohistochemical 4 (IHC4) score is based on the conventional IHC diagnostic and prognostic scores for ER, PR, HER2, and Ki-67, and a recurrence risk score is derived by assigning different weights to each of the IHC parameters to assess the risk of postoperative recurrence in patients with breast cancer [36]. Here, ERBB2 is linked to breast cancer.